DNA synthesis

Home » Emerging technologies » DNA synthesis

Evonetix appoints Stephanie Brooking as Head of Product Management

CAMBRIDGE, UK, 14 January 2019 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, today announced it has appointed Stephanie Brooking...

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

News digest #255 – What is the future of DNA synthesis? + The next generation of natural sweeteners

Your guide to what’s new in synthetic biology Hi %%first_name%%, What is the future of DNA synthesis? Check out our overview of the DNA synthesis panel at SynBioBeta 2018, where five experts discussed the...

DNA synthesis panel

The future of DNA synthesis

evonetix

Evonetix establishes scientific advisory board

plant

Four synthetic biology startups to watch in 2019

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

DNA Script

DNA Script Creates U.S. Subsidiary and Expands Executive Team in the U.S.

Emily Leproust

A big IPO for synthetic biology: Twist rings the Nasdaq bell today

News Digest #247 – Twist’s IPO, Ginkgo’s Bioworks4, iGEM’s winners, and Geltor’s Series A

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

Touchlight Genetics

Janssen Biotech and Touchlight announce collaboration

Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy

Synpromics

Synpromics Promoter Technology Moves Closer to the Clinic

Synpromics

Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform